33 related articles for article (PubMed ID: 34280531)
1. Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient.
Botelho MCB; Ferreira LL; Fikaris S; Prado-Ribeiro AC; Soubhia AMP; Biasoli ER; Miyahara GI; Bernabé DG
Head Neck Pathol; 2021 Sep; 15(3):1069-1073. PubMed ID: 33372239
[TBL] [Abstract][Full Text] [Related]
2. Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil.
Carvalho JP; Assis TM; Simões TC; Cota G
Rev Soc Bras Med Trop; 2021; 54():e04542020. PubMed ID: 33533816
[TBL] [Abstract][Full Text] [Related]
3. Overlapping between squamous cell carcinoma and mucocutaneous leishmaniasis in a diabetic patient.
Khaddam H; Kheder K; Sabouni R; Al Mahmoud Y; Nabhan R
Oxf Med Case Reports; 2024 Feb; 2024(2):omad153. PubMed ID: 38370500
[TBL] [Abstract][Full Text] [Related]
4. Case Report: First Report of Mucocutaneous Leishmaniasis in Algeria: Observations from a Case Report.
Seklaoui N; Izri A; Tablit I; Chergou M; Hamrioui B; Akhoundi M
Am J Trop Med Hyg; 2024 Jun; ():. PubMed ID: 38861965
[TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous Leishmaniasis with Rare Manifestation in the Nasal Mucosa and Cartilage Bone Septal.
Casalle N; de Barros Pinto Grifoni L; Bosco Mendes AC; Delort S; Massucato EMS
Case Rep Infect Dis; 2020; 2020():8876020. PubMed ID: 33029438
[No Abstract] [Full Text] [Related]
6. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722
[No Abstract] [Full Text] [Related]
7. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of miltefosine monotherapy and pentoxifylline associated with pentavalent antimony in treating mucosal leishmaniasis.
Ventin F; Cincurá C; Machado PRL
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):219-225. PubMed ID: 29411659
[TBL] [Abstract][Full Text] [Related]
9. Successful combined therapy with Glucantime™ and pentoxifylline for the nasal mucosal lesion recently developed in a leishmaniasis patient having untreated cutaneous lesion for seven decades.
Brustolin AÁ; Ramos-Milaré ÁCFH; de Castro KR; Mota CA; Pelloso SM; Silveira TGV
Parasitol Int; 2021 Dec; 85():102422. PubMed ID: 34280531
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Goyonlo VM; Vahabi-Amlashi S; Taghavi F
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
[TBL] [Abstract][Full Text] [Related]
11. Mucosal Leishmaniasis of the lip: Report of an Exuberant case in a Young man.
de Arruda JAA; Tomo S; Cunha JLS; Guevara JR; Martínez I; Reyes O; Bracho V; Sanchez C; de Andrade BAB; Villarroel-Dorrego M
Head Neck Pathol; 2023 Jun; 17(2):540-545. PubMed ID: 36346574
[TBL] [Abstract][Full Text] [Related]
12. Unusual manifestation of genital cutaneous leishmaniasis in an immunocompetent patient from São Paulo, Brazil: A case report.
Reis LC; Lindoso JAL; Celeste BJ; Braz LMA; Ramos-Sanchez EM; Yamashiro-Kanashiro EH; Goto H; Oyafuso LKM
Rev Soc Bras Med Trop; 2021; 54():e0514-2020. PubMed ID: 33759920
[TBL] [Abstract][Full Text] [Related]
13. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.
Ramos TD; Silva JD; da Fonseca-Martins AM; da Silveira Pratti JE; Firmino-Cruz L; Maciel-Oliveira D; Dos-Santos JS; Tenorio JIN; de Araujo AF; Freire-de-Lima CG; Diaz BL; Cruz FF; Rocco PRM; de Matos Guedes HL
Stem Cell Res Ther; 2020 Aug; 11(1):374. PubMed ID: 32867857
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
